Alzheimer’s, Parkinson’s, multiple sclerosis, cancer: they’re all diseases that are, to this day, largely a mystery, and treatment options are scarce. But thanks to stem cells,...
On October 19th and 20th, we hosted the sixteenth annual NYSCF Conference on translational stem cell research. This year’s meeting, held virtually for the second consecutive...
NYSCF recently began a new partnership with Quris – an artificial intelligence (AI) innovator – to advance AI-driven strategies for predicting clinical safety and efficacy of...
New York, NY (October 19, 2021) – The New York Stem Cell Foundation (NYSCF) today announced the 2021 class of NYSCF – Robertson Investigators, welcoming six...
Annually for the past 15 years, the NYSCF Conference has showcased the latest cutting-edge findings in translational stem cell research, gathering world-renowned multi-disciplinary speakers and 500+...
The Problem: Colon cancer is responsible for the second highest number of cancer deaths in the United States, and third highest worldwide. The majority of cases...
The Problem: If you’ve set up your phone to unlock when it sees your face, then you’re already familiar with image recognition technology. Image recognition software...
What’s so special about stem cells, and what kinds of careers can you have in this exciting field? This month, NYSCF hosted two events for students...
The Problem: We’ve all heard of – or experienced – hair loss due to stress. But the reasons behind this phenomenon have been unexplored. The Study:...
At the root of every major disease of our time is the simple question: what is going wrong with our cells? Once scientists know exactly how...
“My oldest son, Andrew, is a cancer survivor,” said Tony Coles, MD, PhD, CEO of Cerevel Therapeutics. “He was afflicted with non-Hodgkins lymphoma when he...
Top row: Drs. Raffaella Di Micco, Samantha Morris, José Ordovás-Montañés. Bottom row: Drs. Jiami Guo, David Schneider, John Tuthill New York, NY (October 20, 2020) – The...
The Context: We’ve all heard that stress can turn your hair gray. But there hasn’t been much scientific evidence that this is true — and if...
In 2006, Shinya Yamanaka, MD, PhD, made a discovery that revolutionized biomedical research and earned him a Nobel Prize. His lab found that stem cells, the...
The Context: Stem cells are advantageous for disease research because of their ability to become any type of cell in the body, allowing scientists to see...
The Context: Humans inherit two sets of genes, one from each biological parent. Some of these genes have only one parent’s copy activated, while the other...
The key to fixing many devastating diseases and injuries could very well lie in regenerative medicine. The secret? Stem cell research. At NYSCF’s recent event, “Stem...
The NYSCF – Druckenmiller Fellowship Program supports the most talented postdoctoral scientists at critical junctures in their careers who are in the pursuit of innovative and...
The Context: What makes stem cells special is their ability to turn into other cell types in the body (a characteristic called “pluripotency”). Our understanding of...
Building a strong community of researchers committed to advancing cutting-edge science is critical for getting treatments and cures to patients as quickly as possible. Because of...
“We had the foundational tools we needed to move our research from academia to biotech,” remarked NYSCF – Robertson Investigator Alumnus Dr. Paul Tesar. “We had...
Last week, thousands of researchers and thought leaders gathered at the annual Phacilitate Leaders World and World Stem Cell Summit in Miami to discuss recent advancements...
Research teams will use stem cell and gene editing technologies to advance cell-based therapies for devastating diseases New York, New York (January 9, 2019) – The...
“It takes 13 years—after you have sunk 4 billion dollars into a drug—to figure out whether or not it will succeed, and your chance of being...
Our skin is made up of three layers. The top layer – the epidermis – contains epithelial cells, which provide a barrier between us and the...
